Uses Of Cefaclor

Cefaclor is an antibiotic medication used to treat a wide range of bacterial infections. It is a cephalosporin antibiotic, which is related to penicillin. It works by stopping the growth of bacteria. Cefaclor is available in many forms, such as capsules, tablets, suspension, and extended-release tablets.

Cefaclor is used to treat a variety of bacterial infections, such as bronchitis, pneumonia, ear infections, sinus infections, skin infections, and urinary tract infections. It is also used to prevent certain types of bacterial infections in people who have had a bone marrow transplant.

Active Ingredients and Synonyms
The active ingredient in Cefaclor is cefaclor monohydrate. Other synonyms for this medication include Cefaclorum, Cefaclorum monohydricum, and Cefaclorum monohydricum monohydrate.

Cefaclor is available in a variety of dosages, including 250 mg, 500 mg, and 750 mg. Your doctor will determine the appropriate dosage for you, depending on the type and severity of your infection.

Side Effects
The most common side effects of Cefaclor include nausea, vomiting, diarrhea, and abdominal pain. Other possible side effects include headache, dizziness, rash, and itching. If you experience any of these side effects, you should contact your doctor.

Before taking Cefaclor, tell your doctor if you are allergic to cephalosporins, penicillins, or other medications. Also, tell your doctor if you have kidney or liver disease, or if you are pregnant or breastfeeding.

Cefaclor is an effective antibiotic used to treat a variety of bacterial infections. It is important to take the medication as directed by your doctor to avoid serious side effects. If you experience any side effects, contact your doctor immediately.

1. Cefaclor (Ceclor) Uses, Dosage, Side Effects – (2020). Retrieved 6 November 2020, from
2. Cefaclor (Oral Route) Description and Brand Names – Mayo Clinic. (2020). Retrieved 6 November 2020, from
3. Cefaclor – Side Effects, Dosage, Interactions – Drugs – Everyday Health. (2020). Retrieved 6 November 2020, from

Leave a Comment

Your email address will not be published. Required fields are marked *